We have developed a combinatory antibody-antigen microarray for direct screening of multiple single-chain fragment variable (scFv) clones with no need for pre-purification or enrichment before screening. The straightforward workflow allows for early selection of binders to predefined peptide and glycopeptide targets. A capture antibody is contact printed on microarray slides, side by side with the antigens of interest. A large number of scFv clones, in supernatants, are printed on top of the capture antibody and the antigen in a "spot-on-spot" print. The printed scFv clones, which bind to the capture antibody, are detected using biotinylated antigen, while the binding of scFv clones to the printed antigen is detected through a mouse anti-ta...
We describe here a method, based on iterative colony filter screening, for the rapid isolation of bi...
The mouse monoclonal antibody (mAb) technology still represents a key source of reagents for researc...
Phage display technology has become a key player in the selection of affinity reagents from antibody...
<p><b>A</b>) Capture antibody and peptides are printed on a microarray slide before adding scFv in a...
The generation of recombinant antibodies by phage display in high-throughput demands fast downstream...
AbstractMonoclonal antibodies are valuable laboratory reagents and are increasingly being exploited ...
Automation is the key approach for genomewide and proteomewide screening of function and interaction...
Automation is the key approach for genomewide and proteomewide screening of function and interaction...
Antibody phage display technology is well established and widely used for selecting specific antibod...
Several synthetic antibody phage display libraries have been created and used for the isolation of h...
<div><p>Several synthetic antibody phage display libraries have been created and used for the isolat...
Antibody discovery by phage display consists of two phases, i.e., the binding phase and the amplific...
International audienceBACKGROUND: Due to their unique ability to bind their targets with high fideli...
Novel affinity reagents, such as single chain (scFv) antibody fragments, can be generated by isolati...
ABSTRACT: High-affinity antibodies binding to linear peptides in solution are a prerequisite for per...
We describe here a method, based on iterative colony filter screening, for the rapid isolation of bi...
The mouse monoclonal antibody (mAb) technology still represents a key source of reagents for researc...
Phage display technology has become a key player in the selection of affinity reagents from antibody...
<p><b>A</b>) Capture antibody and peptides are printed on a microarray slide before adding scFv in a...
The generation of recombinant antibodies by phage display in high-throughput demands fast downstream...
AbstractMonoclonal antibodies are valuable laboratory reagents and are increasingly being exploited ...
Automation is the key approach for genomewide and proteomewide screening of function and interaction...
Automation is the key approach for genomewide and proteomewide screening of function and interaction...
Antibody phage display technology is well established and widely used for selecting specific antibod...
Several synthetic antibody phage display libraries have been created and used for the isolation of h...
<div><p>Several synthetic antibody phage display libraries have been created and used for the isolat...
Antibody discovery by phage display consists of two phases, i.e., the binding phase and the amplific...
International audienceBACKGROUND: Due to their unique ability to bind their targets with high fideli...
Novel affinity reagents, such as single chain (scFv) antibody fragments, can be generated by isolati...
ABSTRACT: High-affinity antibodies binding to linear peptides in solution are a prerequisite for per...
We describe here a method, based on iterative colony filter screening, for the rapid isolation of bi...
The mouse monoclonal antibody (mAb) technology still represents a key source of reagents for researc...
Phage display technology has become a key player in the selection of affinity reagents from antibody...